Table 2.
Median doses for definitive RT and postoperative RT as well as pelvic lymph nodes
| Median total dose in EQD2(1.5 Gy) [Gy] | Median single dose [Gy] |
n = 109 | |
|---|---|---|---|
| Definitive RT of prostate |
77.76 (range: 64.49–84.00) |
2.00 (range: 1.80–3.00) |
Conventional FX: 79 (72.5%) Moderate HFX: 20 (18.3%) Missing: 9 (8.3%) Brachytherapy: 1 (0.9%) with 145 Gy |
| Definitive RT of pelvic LNs |
47.52 (range: 42.43–66.00) |
1.80 (range 1.60–2.00) |
Conventional FX: 107 (98.2%) Moderate HFX: 0 (0%) Missing: 2 (1.8%) |
| Postoperative RT of prostate bed |
66.00 (range: 60.00–74.00) |
2.00 (range: 1.80–2.00) |
Conventional FX: 106 (97.2%) Moderate HFX: 0 (0%) Missing: 3 (2.8%) |
| Postoperative RT of pelvic LNs |
47.52 (range: 41.76–62.79) |
1.80 (range: 1.40–2.00) |
Conventional FX: 107 (98.2%) Moderate HFX: 0 (0%) Missing: 2 (1.8%) |
RT = radiotherapy, LN = lymph nodes, (H)FX = (hypo)fractionation, EQD2(1.5 Gy) equivalent dose at fractionation of 2 Gy with α/β = 1.5 Gy